Avantax Advisory Services’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$62.7K Sell
12,133
-601
-5% -$3.6K ﹤0.01% 2318
2025
Q1
$84.8K Buy
12,734
+211
+2% +$1.6K ﹤0.01% 2168
2024
Q4
$92.3K Sell
12,523
-606
-5% -$4.35K ﹤0.01% 2126
2024
Q3
$91.9K Sell
13,129
-443
-3% -$2.66K ﹤0.01% 2075
2024
Q2
$66.6K Buy
+13,572
New +$81.8K ﹤0.01% 2033

Other funds holding LFST

Avantax Advisory Services's LFST Position: Q2 2025 in Review

Avantax Advisory Services reduced its Lifestance Health (LFST) stake by 4.7% in Q2 2025, selling an estimated $3.6K and leaving 12,133 shares worth $62.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Avantax Advisory Services first reported a position in LFST in Q2 2024 and has held it in 5 quarters since. The position peaked at $92.3K in Q4 2024. 194 funds tracked by Wall St. Rank hold LFST as of Q2 2025.

  • Avantax Advisory Services held 12,133 shares of Lifestance Health worth $62.7K as of Q2 2025.
  • Avantax Advisory Services sold 601 Lifestance Health shares in Q2 2025, an estimated $3.6K.
  • Lifestance Health made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2318 holding.
  • Avantax Advisory Services first reported a position in Lifestance Health in Q2 2024 and has held it in 5 quarters since.
  • Avantax Advisory Services's Lifestance Health position peaked at $92.3K in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.